Peter Traber, M.D. is a biotech executive, physician and molecular biologist who presently serves as CEO (since March 2011) and Chief Medical Officer (since June 2010) of Galectin Therapeutics.
Dr. Traber is President Emeritus of Baylor College of Medicine, where he was Chief Executive Officer from 2003 to 2008. From 2000 to 2003 he was Senior Vice President of Clinical Development and Medical Affairs and Chief Medical Officer of GlaxoSmithKline plc.
Dr. Traber previously served as Chief Executive Officer of the University of Pennsylvania Health System and was Chair of the Department of Internal Medicine and Chief of Gastroenterology for the University of Pennsylvania School of Medicine. He has also managed a molecular biology research laboratory and published over 100 articles of original research, reviews, and book chapters.
Dr. Traber received his M.D. from Wayne State School of Medicine and his B.S. in chemical engineering from the University of Michigan.
